Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity Article

cited authors

  • Socinski, MA; Zhang, C; Herndon, JE; Dillman, RO; Clamon, G; Vokes, E; Akerley, W; Crawford, J; Perry, MC; Seagren, SL; Green, MR

authors

Publication Date

  • July 1, 2004

webpage

published in

category

keywords

  • chemoradiation
  • combined modality therapy
  • non-small-cell lung cancer
  • prognostic factors

start page

  • 1033

end page

  • 1041

volume

  • 15

issue

  • 7